Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients

C. C. Wang, C. H. Lin, S. L. Cheng, M. C. Chan, J. Y. Hsu, L. W. Hang, S. D. W. Perng, C. J. Yu, H. C. Wang (Kaohsiung, Changhua, Taipei, Taichung, Taiwan)

Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Session: Non inflammatory monitoring of airway diseases
Session type: Poster Discussion
Number: 2998
Disease area: Airway diseases, Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. C. Wang, C. H. Lin, S. L. Cheng, M. C. Chan, J. Y. Hsu, L. W. Hang, S. D. W. Perng, C. J. Yu, H. C. Wang (Kaohsiung, Changhua, Taipei, Taichung, Taiwan). Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients. Eur Respir J 2014; 44: Suppl. 58, 2998

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of CAT and CCQ in a clinical COPD population
Source: International Congress 2014 – Clinical presentations
Year: 2014

Exacerbations and healthcare resource utilization among COPD patients in Sweden
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Integrated care reduces hospital utilization among patients with severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Effectiveness of a comprehensive management program of fragile COPD patients
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014



Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014


Relationship of mMRC and CAT scores in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013

Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014

Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014


Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014

Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014